Delivery details +
Order by fax
Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
- PDF: Delivered by email usually within 12 to 24 UK business hours.
Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile
- Product Code:GMD12609
- Publication Date:July 2009
- Publisher:Global Markets Direct
- Product Type: Report
- Pages:22
Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile
Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Savient Pharmaceuticals, Inc. (Savient) is a specialty pharmaceuticals company. It is principally engaged in research, development, manufacture, and marketing of pharmaceutical products. The company is formerly called as Bio-Technology General. It operates principally in the U.S., the U.K. and Israel. The company is headquartered in East Brunswick, New Jersey of the United States.
Global Market Direct's Savient Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 7
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details 9
Divestiture - Assets 9
Indevus Acquires Delatestryl From Savient Pharmaceuticals 9
Barr Pharmaceuticals Acquires Rights Of Mircette From Organon And Savient 10
Savient Pharmaceuticals Sells Its Global Biologics Manufacturing Business To Ferring International 11
Divestiture - Company 12
Ferring Acquires Bio-Technology General From Savient Pharmaceuticals 12
Equity Offering 13
Savient Pharmaceuticals Announces Registered Direct Offering Of $31 Million 13
Partnerships 14
Savient Pharmaceuticals Enters Into Agreement With Watson Pharmaceuticals 14
Cytogen Signs An Agreement With Savient Pharmaceuticals 15
Savient Signs Agreement With Ferring Pharmaceuticals 16
Savient Pharmaceuticals Terminates Its Licensing Agreement With Berna Biotech 17
Private Equity 18
Savient Pharmaceuticals Sells Its Stake In Rosemont Pharmaceuticals To Close Brothers Private Equity 18
Savient Pharmaceuticals Sells Its Stake In Omrix Biopharmaceuticals To Catalyst Investments 19
Key Competitors 20
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About Global Markets Direct 22
Contact Us 22
Disclaimer 22
List of Tables
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 5
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Savient Pharmaceuticals, Inc., Deals By Sector, 2004 to YTD 2009 7
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 8
Indevus Acquires Delatestryl From Savient Pharmaceuticals 9
Barr Pharmaceuticals Acquires Rights Of Mircette From Organon And Savient 10
Savient Pharmaceuticals Sells Its Global Biologics Manufacturing Business To Ferring International 11
Ferring Acquires Bio-Technology General From Savient Pharmaceuticals 12
Savient Pharmaceuticals Announces Registered Direct Offering Of $31 Million 13
Savient Pharmaceuticals Enters Into Agreement With Watson Pharmaceuticals 14
Cytogen Signs An Agreement With Savient Pharmaceuticals 15
Savient Signs Agreement With Ferring Pharmaceuticals 16
Savient Pharmaceuticals Terminates Its Licensing Agreement With Berna Biotech 17
Savient Pharmaceuticals Sells Its Stake In Rosemont Pharmaceuticals To Close Brothers Private Equity 18
Savient Pharmaceuticals Sells Its Stake In Omrix Biopharmaceuticals To Catalyst Investments 19
Savient Pharmaceuticals, Inc., Key Employees 20
Savient Pharmaceuticals, Inc., Other Locations 21
Savient Pharmaceuticals, Inc., Subsidiaries 21
List of Figures
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 4
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 5
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 6
Savient Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 7
